icon-folder.gif   Conference Reports for NATAP  
 
  65th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 7-11 2014
Back grey_arrow_rt.gif
 
 
 
A Baseline Predictive Tool for Selecting HBeAg-Negative Chronic Hepatitis B Patients Who Have a High Probability of Achieving Sustained Immune Control with Peginterferon Alfa-2a
 
 
  Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
 
P. Lampertico1, V. Rothe2, A. Caputo3, G.V. Papatheodoridis4 1AM & A Migliavacca Center for Liver Disease, 1st Gastroenterology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, UniversitÓ degli Studi di Milano, Milan, Italy; 2IST GmbH, Mannheim, Germany; 3Roche S.p.A., Monza, Italy; 4Department of Gastroenterology, Athens University Medical School, Laiko General Hospital, Athens, Greece

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif